ARCHIVES

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

This article is from The Cancer Letter archive.

Vol. 03 No. 43 | October 28, 1977

Download PDF Visit The Full Archive

Related Articles

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011

NCI-Approved Clinical Trials

July 30, 2010

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

October 11, 1996

Detroit Center Formally Recognized As Comprehensive

August 4, 1978